Astrana Health (ASTH) Revenue (2010 - 2026)

Astrana Health has disclosed Revenue across 17 years of filings, most recently posting $965.1 million for Q1 2026.

• Revenue for Q1 2026 came in at $965.1 million, up 55.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 billion (up 56.69% YoY), and the FY2025 annual result was $3.2 billion, up 56.39% from the prior year.
• Revenue came in at $965.1 million for Q1 2026 at Astrana Health, up from $950.5 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $965.1 million in Q1 2026 to a low of $263.3 million in Q1 2022.
• The 5-year median for Revenue is $404.4 million (2024), against an average of $512.5 million.
• Across the five-year window, Revenue grew 9.83% in 2023 and surged 99.71% in 2025, its largest moves.
• Astrana Health's Revenue stood at $294.2 million in 2022, then climbed by 20.0% to $353.0 million in 2023, then surged by 88.43% to $665.2 million in 2024, then soared by 42.89% to $950.5 million in 2025, then advanced by 1.53% to $965.1 million in 2026.
• The last three Revenue figures came in at $965.1 million (Q1 2026), $950.5 million (Q4 2025), and $956.0 million (Q3 2025), per Business Quant data.